Article
Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 1 Feb 2020
Weinbaum Barbara, Williams Analee, Hadad Ronza, Vinluan Bryan, Puolakkainen Mirja, Unemo Magnus, Getman Damon
Abstract excerpt
The Finnish new variant of Chlamydia trachomatis (FI-nvCT) is escaping diagnostics in Finland, Norway and Sweden. We have developed and validated an Aptima-format nucleic acid amplification test (NAAT) designed specifically to detect the FI-nvCT. This NAAT has high sensitivity (100%) and specificity (100%) for the FI-nvCT strain, enabling further investigation of the geographic distribution, prevalence and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.